Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
11 (
01
); 003-008
doi:
10.1055/s-0040-1721215

Correlation of Nuclear Morphometry with Clinicopathologic Parameters in Malignant Breast Aspirates

Department of Pathology, SHKM GMC Nalhar, Nuh, Haryana, India
Department of Pathology, Army Hospital (Research and Referral), New Delhi, India

*Corresponding author: Shilpa Garg, Nuh, Haryana, India. shilpagoyal15@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Shilpa Garg
FI14119-4 Shilpa Garg

Background Nuclear size, shape, chromatin pattern, and nucleolar size and number have all been reported to change in breast cancer.

Aim The aim of the study was to quantify nuclear changes on malignant breast aspirates using morphometry and to correlate the morphometric parameters with clinicopathologic features such as cytologic grade, tumor size, lymph node status, mitotic index, and histopathologic grade.

Materials and Methods Forty-five cases of carcinoma breast diagnosed on cytology were included in this study. Cytologic grading was performed as per the Robinson's cytologic grading system. Nuclear morphometry was done on Papanicolaou stained smears. One hundred nonoverlapping cells per case were evaluated. Both geometrical and textural parameters were evaluated.

Results Comparison of cytologic grades with most morphometric features (nuclear area, perimeter, shape, long axis, short axis, intensity, total run length, and TI homogeneity) was highly significant on statistical analysis. Correlation with tumor size yielded significant results for nuclear area, perimeter, long and short axes, and intensity with p < 0.05. The study of lymph node status and morphometry showed a highly significant statistical association with all the parameters. Mitotic count was significantly associated with all the geometric parameters and one textural parameter (total run length). On correlation of ductal carcinoma in situ and histopathological Grades 1 to 3 with morphometry, it was found that all the parameters except long–run emphasis were highly significant with p < 0.001.

Conclusion Morphometry as a technique holds immense promise in prognostication in breast carcinoma.

Keywords

PubMed

Introduction

Breast cancer is the second most common cancer among women in India and accounts for 7% of the global burden of breast cancer and one-fifth of all cancers among women in India.12

Prognosis of breast cancer depends on multiple clinicopathological parameters that include tumor size, lymph node status, estrogen receptor status, tumor histologic grading, and cell proliferation index. These parameters are studied on surgically excised specimens. Treatment decisions are taken by the clinicians depending on these factors. Fine-needle aspiration cytology (FNAC) is routinely used as a preoperative diagnostic tool in suspected cases of breast cancer. Information obtained by fine-needle aspiration can be extremely useful in patient management.

This study was planned with the aim to quantify nuclear changes on malignant breast aspirates using morphometry and to correlate the morphometric parameters with clinicopathologic features such as cytologic grade, tumor size, lymph node status, mitotic index, and histopathologic grade.

Materials and Methods

Forty-five cases of carcinoma breast diagnosed on cytology were included in this study. These were categorized as 42 cases of infiltrating duct carcinoma (IDC), not otherwise specified (NOS), and three cases of ductal carcinoma in situ (DCIS) subsequently on histopathology. A concise clinical history, examination, and details of relevant investigations were also obtained. Histopathology material was available in all the 45 cases. Only cases with proven histopathology of DCIS or IDC (NOS) were included in this study. Patients with preoperative radiotherapy or chemotherapy were excluded from this study.

FNAC was performed using standard procedure. Both air-dried and alcohol-fixed smears were stained by Leishman–Giemsa and Papanicolaou (PAP) stains, respectively. Cytologic grading was performed as per the Robinson's cytologic grading system considering six parameters, namely cell dissociation, cell size, cell uniformity, nucleoli, nuclear margin, and chromatin.

Scores of 1 to 3 were assigned for each of the six parameters—cell dissociation, cell size, cell uniformity, nucleoli, nuclear margin, and chromatin, and they were totaled to classify the lesions into Grade 1, score 6 to 11; Grade 2, score 12 to 14; and Grade 3, score 15 to 18.3

Nuclear morphometry was done in all the cases on smears stained with PAP stain using the Defense Bioengineering and Electromedical Laboratory Cytoscan indigenously developed by Defense Research and Development Organization, New Delhi, India. One hundred nonoverlapping cells per case were evaluated. Both geometrical and textural parameters were evaluated. Geometrical parameters included nuclear area, perimeter, nuclear shape, long axis, short axis, and intensity. Textural parameters were long-run emphasis (measuring coarseness of nuclear chromatin), total run length (measuring proportion of coarse to fine chromatin), and T1 homogeneity (measuring homogeneity of chromatin distribution).

It was proposed to correlate cytological grade, tumor size, lymph node status, mitotic count, histological grade versus nuclear area, perimeter, nuclear shape, long axis, short axis, intensity, long-run emphasis, total run length, and T1 homogeneity and see if the association was statistically significant.

Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) software for Windows, version 17.0 (SPSS, Chicago, Illinois, United States). Continuous variables were presented as mean ± standard deviation (SD) and compared using the two-tailed, independent sample t-test, and one-way analysis of variance test. Tests were performed at significance level 0.05, that is, p < 0.05 was taken to indicate a statistically significant difference.

Results

The study included 45 cases of carcinoma breast diagnosed and graded on cytology. There were 44 female and 1 male patients. The mean age at diagnosis across the groups was 49.8 ± 13.2 years and that in the DCIS group was 35.3 ± 1.5 years; IDC (NOS) with negative nodes was 50.3 ± 13.5 and IDC (NOS) with positive nodes was 51.2 ± 12.9 years.

Histopathology was available in all the 45 cases.

There were nine cases in cytologic Grade 1, 26 in Grade 2, and 10 cases in cytologic Grade 3 (Figs. 123. Correlation of nuclear morphometry with cytologic grades was performed. It was found that nuclear area, perimeter, shape, long axis, short axis, intensity, total run length, and T1 homogeneity were highly significant on statistical analysis (Table 1).

Cytological Grade 1 showing cell clustering and atypical mitoses (Papanicolaou, x400).
Fig. 1: Cytological Grade 1 showing cell clustering and atypical mitoses (Papanicolaou, x400).
Cytological Grade 2 showing mixture of moderately pleomorphic single cells and clusters (Papanicolaou, x400).
Fig. 2: Cytological Grade 2 showing mixture of moderately pleomorphic single cells and clusters (Papanicolaou, x400).
Cytological Grade 3 showing cell size >5 red blood cell and prominent nucleoli with coarsely granular chromatin (Papanicolaou, x400).
Fig. 3: Cytological Grade 3 showing cell size >5 red blood cell and prominent nucleoli with coarsely granular chromatin (Papanicolaou, x400).
Table 1
Correlation of cytologic grades with nuclear morphometry grades

Morphometric parameter

Cytology Grade 1 (n = 9)

Cytology Grade 2 (n = 26)

Cytology Grade 3 (n = 10)

p-Value (one–way ANOVA test)

Nuclear area

78.21 ± 12.40

93.12 ± 13.85

115.89 ± 19.03

<0.001a

Perimeter

31.08 ± 4.24

36.81 ± 3.77

39.33 ± 5.32

<0.001a

Shape

1.05 ± 0.01

1.09 ± 0.04

1.10 ± 0.03

0.005a

Long axis

11.94 ± 0.97

13.70 ± 1.26

14.82 ± 1.19

<0.001a

Short axis

8.24 ± 0.81

9.33 ± 1.12

10.20 ± 0.95

0.001a

Intensity

100.12 ± 19.03

119.03 ± 17.23

131.61 ± 18.04

0.002a

Long-run emphasis

1.19 ± 0.08

1.20 ± 0.08

1.19 ± 0.05

0.906

Total run length

3433.29 ± 808.54

4140.06 ± 1065.69

5171.36 ± 982.90

0.002a

Tl homogeneity

0.006 ± 0.0004

0.0008 ± 0.001

0.007 ± 0.0003

<0.001a

Abbreviation: ANOVA, analysis of variance.

Statistically significant.

Majority of our cases had a tumor size <5 cm (n = 38, 84.4%). There were seven cases with tumor size >5 cm. Comparison of morphometric features with tumor size yielded significant results for nuclear area, perimeter, long and short axes, and intensity with p < 0.05 for these parameters (Table 2).

Table 2
Correlation of morphometric parameters with tumor size

Morphometric parameter

Tumor size <5 cm (n = 38)

Tumor size ³5 cm (n = 7)

p-Value (independent sample t–test)

Nuclear area

91.92 ± 18.48

112.99 ± 12.99

0.006a

Perimeter

35.38 ± 4.95

40.82 ± 1.69

0.006a

Shape

1.08 ± 0.04

1.11 ± 0.03

0.076

Long axis

13.39 ± 1.53

14.75 ± 0.59

0.025a

Short axis

9.12 ± 1.20

10.31 ± 0.46

0.013a

Intensity

114.76 ± 20.19

135.85 ± 7.04

0.009a

Long–run emphasis

1.19 ± 0.08

1.20 ± 0.08

0.782

Total run length

4095.59 ± 1160.11

4946.06 ± 710.60

0.068

Tl homogeneity

0.0071 ± 0.0012

0.0078 ± 0.0015

0.252

Statistically significant.

There were 30 cases (66.7%) with positive lymph nodes. Evaluation of lymph node status (positive/negative) versus morphometry showed a highly significant association between all the geometric as well as textural parameters, that is, nuclear area, perimeter, shape, long and short axes, intensity, long-run emphasis, total run length, and Tl homogeneity (Table 3). The three cases of DCIS were grouped in the node–negative category since none of them had positive lymph nodes. Mitotic count was, on the other hand, significantly associated with geometric parameters such as nuclear area, perimeter, shape, long axis, short axis, and intensity. Among the textural parameters, only total run length, signifying proportion of coarse to fine chromatin, was found to be significantly associated with mitotic count on statistical analysis. Majority of our cases were in the <6 mitosis categories (n = 33, 73.3%) (Table 4).

Table 3
Correlation of morphometric parameters with lymph node status

Morphometric parameter

Lymph node status negative (n = 15)

Lymph node status positive (n = 30)

p-Value (independent sample t–test)

Nuclear area

76.65 ± 12.46

104.47 ± 14.81

<0.001a

Perimeter

30.49 ± 3.29

39.10 ± 2.67

<0.001a

Shape

1.05 ± 0.02

1.11 ± 0.03

<0.001a

Long axis

11.92 ± 0.98

14.44 ± 0.89

<0.001a

Short axis

8.06 ± 0.84

9.92 ± 0.79

<0.001a

Intensity

98.19 ± 12.18

127.97 ± 15.60

<0.001a

Long-run emphasis

1.16 ± 0.05

1.21 ± 0.08

0.019a

Total run length

3260.32 ± 818.74

4711.66 ± 958.68

<0.001a

Tl homogeneity

0.0064 ± 0.0008

0.008 ± 0.001

0.003a

Statistically significant.

Table 4
Correlation of morphometric parameters with mitotic rate

Morphometric parameter

Mitosis <6 (n = 33)

Mitosis ³6 (n = 12)

p-Value (independent sample t–test)

Nuclear area

87.86 ± 14.30

115.39 ± 16.69

<0.001a

Perimeter

34.72 ± 4.58

40.36 ± 3.68

<0.001a

Shape

1.08 ± 0.03

1.12 ± 0.028

0.002a

Long axis

13.11 ± 1.36

14.93 ± 1.04

<0.001a

Short axis

8.96 ± 1.12

10.24 ± 0.86

<0.001a

Intensity

111.89 ± 18.49

134.96 ± 14.69

0.003a

Long–run emphasis

1.19 ± 0.08

1.21 ± 0.07

0.482

Total run length

3849.13 ± 995.71

5269.46 ± 832.49

<0.001a

Tl homogeneity

0.0073 ± 0.001

0.0071 ± 0.0012

0.510

Statistically significant.

The histopathological examination of 42 cases showed IDC (NOS) and three cases (6.7%) of DCIS. Among the 42 cases of IDC (NOS), there were 6, 27, and 9 cases in Grades 1, 2, and 3, comprising 13.3, 60, and 20%, respectively. On correlation of DCIS and histopathological Grades 1 to 3 with morphometry, it was found that all the parameters except long–run emphasis, that is, nuclear area, perimeter, shape, long and short axes, intensity, total run length, and Tl homogeneity were highly significant on statistical analysis with all having p < 0.001 (Table 5).

Table 5
Correlation of morphometric parameters with histopathological grading

Morphometric parameter

DCIS (n = 3)

Histopathology Grade 1 (n = 6)

Histopathology Grade 2 (n = 27)

Histopathology Grade 3 (n = 9)

p-Value (one–way ANOVA test)

Nuclear area

85.63 ± 5.10

69.81 ± 8.08

93.08 ± 12.78

118.9 ± 14.63

<0.001a

Perimeter

32.37 ± 2.15

29.58 ± 4.36

35.35 ± 3.94

40.19 ± 4.31

<0.001a

Shape

1.04 ± 0.005

1.05 ± 0.01

1.09 ± 0.03

1.11 ± 0.03

<0.001a

Long axis

12.02 ± 0.59

11.64 ± 1.01

13.66 ± 1.18

15.12 ± 0.70

<0.001a

Short axis

8.63 ± 0.54

7.72 ± 0.72

9.31 ± 1.03

10.54 ± 0.43

<0.001a

Intensity

92.64 ± 6.21

100.62 ± 20.80

117.65 ± 17.25

135.33 ± 10.95

<0.001a

Long-run emphasis

1.17 ± 0.05

1.20 ± 0.09

1.20 ± 0.09

1.19 ± 0.05

0.934

Total run length

4043.24 ± 209.25

2836.74 ± 496.43

4136.50 ± 996.54

5446.82 ± 752.46

<0.001a

Tl homogeneity

0.006 ± 0.0006

0.006 ± 0.000

0.008 ± 0.001

0.007 ± 0.001

<0.001a

Abbreviations: ANOVA, analysis of variance; DCIS, ductal carcinoma in situ.

Statistically significant.

Discussion

Alterations in nuclear structure are the morphologic hallmark of cancer diagnosis. Nuclear size, shape, chromatin pattern, and nucleolar size and number have all been reported to change in breast cancer. Attempts to quantify nuclear alterations to establish grading systems, predict prognosis, and/or set guidelines for therapy have met with varied success.4

This study was planned to evaluate the role of nuclear morphometry vis-a-vis various clinicopathologic parameters in breast cancer. The aim was to evaluate each of these criteria and also to explore the move from subjectivity to quantified objectivity in breast cancer diagnosis and prognostication.

Diagnostic cutoff values for mean nuclear area (MNA) have been proposed to distinguish between benign and malignant breast lesions. Imprint cytology has been combined with morphometric analysis and has yielded superior results compared with those obtained by imprint cytology and frozen section in breast cancer diagnosis.

With morphometric analysis, it has been reported that there was a significant difference between the means of nuclear area, nuclear perimeter, and nuclear diameter between benign and malignant tissues. Feret circle, a measure of ellipticity, was not significant. These parameters have been advocated to be used intraoperatively in imprint smears to distinguish benign from malignant and suspicious lesions.56

In this study, geometrical (nuclear area, perimeter, nuclear shape, long axis, short axis, and intensity) and textural (long-run emphasis for coarseness of nuclear chromatin, total run length measuring proportion of coarse to fine chromatin, and Tl homogeneity indicating homogeneity of chromatin distribution) parameters were compared with clinicopathologic ones including cytological grade, tumor size, lymph node status, mitotic count, and histological grade, and this association was subjected to statistical analysis.

The value of automated quantitative three-dimensional nuclear morphometry as an objective tool to enable the development of sensitive and specific nuclear grade classification in breast cancer diagnosis has been documented. Abnormal cell nuclei have been found to have more nucleoli, markedly higher density, and clumpier chromatin organization compared with normal ones.7

In the present study, cytologic grades were correlated with nuclear morphometry. Barring long-run emphasis, all the other parameters, namely nuclear area, perimeter, shape, long axis, short axis, intensity, total run length, and Tl homogeneity, were highly significant on statistical analysis with p < 0.05.

Nuclear and histologic grade, lymph node status, tumor size, mitotic activity index, cellularity index, and mean and SD of nuclear area have been reported to be the most important single predictors of prognosis in breast carcinoma. Morphometry significantly adds to the prognosis prediction of lymph node status and tumor size. MNA has been reported to be significantly higher in tumors of the postmenopausal than premenopausal, in LN+ than LN–patients, and in tumors over 3 cm than smaller ones. Significant differences between different clinical stages, histological grades, and histological types of tumors have been reported. Significant correlations have been reported between MNA and histological grade, standard mitotic index, and tumor size.8910

In the present study, the comparison of tumor size with morphometry yielded significant results only for geometric parameters, that is, nuclear area, perimeter, long and short axes, and intensity with p < 0.05. All the geometric and textural parameters, that is, nuclear area, perimeter, shape, long and short axes, intensity, long-run emphasis, total run length, and Tl homogeneity were, on the other hand, found to be significantly associated with lymph node status (positive/negative).

We found mitotic count to have a statistically significant association with all the geometric parameters including nuclear area, perimeter, shape, long axis, short axis, and intensity, with only one textural parameter, that is, total run length, signifying proportion of coarse to fine chromatin being significantly associated. This is majorly in concurrence with the published literature.

The histopathological examination showed IDC (NOS) in 42 cases and DCIS in 3 cases (6.7%) in our study. Among the 42 cases of IDC (NOS), there were 6, 27, and 9 cases in histopathological Grades 1, 2, and 3, comprising 13.3, 60, and 20%, respectively. On correlation of DCIS and histopathological Grades 1 to 3 with morphometry, it was found that all the geometric and most of the textural parameters except long-run emphasis, that is, nuclear area, perimeter, shape, long and short axes, intensity, total run length, and Tl homogeneity were highly significant on statistical analysis with all having p < 0.001.

Conclusion

Based on this study, one can summarize that morphometry as a technique holds immense promise in prognostication in breast carcinoma. It carries the added advantage of being objective and thus is free of individual biases. More studies need to be conducted to further evaluate the strength of this association and its utility in clinical practice.

References

  1. , , , et al . Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16(07):e352-e361.
    [Google Scholar]
  2. , , , et al . Breast cancer status in India: an overview. Biomed Prev Nutr. 2013;3:177-183.
    [Google Scholar]
  3. , , , et al . Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 1994;343:947-949.
    [Google Scholar]
  4. , , . Correlation of nuclear morphometry with progression of breast cancer. Cancer. 1991;68(09):2012-2016.
    [Google Scholar]
  5. , , , , , , . Nuclear morphometry in FNABs of breast disease in Libyans. Anticancer Res. 2008;28:3985-3989.
    [Google Scholar]
  6. , , , et al . Morphometric analysis in breast lesions. A rapid conjunct to intraoperative imprint smears. Middle East J Cancer. 2012;3:1-8.
    [Google Scholar]
  7. , , , , , . Morphometry of tumor cells in different grades and types of breast cancer. Coll Antropol. 2010;34(01):99-103.
    [Google Scholar]
  8. , , , . Grading of ductal breast carcinoma by cytomorphology and image morphometry with histologic correlation. Anal Quant Cytol Histol. 2000;22(03):193-198.
    [Google Scholar]
  9. , , , , . The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985;56(02):374-382.
    [Google Scholar]
  10. , , , . Nuclear morphometry in African breast cancer. Image Anal Stereol. 2011;21:145.
    [Google Scholar]
Show Sections